MIRA INFORM
REPORT
|
Report Date : |
22.08.2011 |
IDENTIFICATION DETAILS
|
Name : |
QUALICAPS INC |
|
|
|
|
Registered Office : |
6505 Franz Warner Pkwy, Whitsett, NC 27377-9215 |
|
|
|
|
Country : |
United States |
|
|
|
|
Year of Establishment : |
1995 |
|
|
|
|
Legal Form : |
Private Subsidiary Company |
|
|
|
|
Line of Business : |
The pharmaceutical and dietary supplement industries |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
$25,000 (USD) |
|
Status : |
Satisfactory |
|
Payment
Behaviour : |
Usually Correct |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2011
|
Country Name |
Previous Rating (31.12.2010) |
Current Rating (31.03.2011) |
|
United States |
a1 |
a1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Company name & address
Qualicaps Inc
6505 Franz Warner Pkwy
Whitsett, NC 27377-9215
United States
Tel:
336-449-7300
Fax: 336-449-3333
Toll Free: 800-227-7853
Web: www.qualicaps.com
Synthesis
Employees: 175
Company Type: Private
Subsidiary
Corporate Family: 14
Companies
Ultimate Parent: Shionogi
& Co., Ltd.
Incorporation Date: 1995
Financials in: USD
(Millions)
Reporting Currency: US
Dollar
Annual Sales: 6.0
Total Assets: NA
Business Description
The pharmaceutical
and dietary supplement industries throughout the world count on Qualicaps to
supply hard two-piece capsules and related manufacturing equipment. With
manufacturing sites in the United States, Europe and Japan, customers can rely
on quick service no matter where they are located. With more than 100 years in
the business, the company has a proven track record in providing the highest
quality capsules. It supplies standard capsules made from gelatin and Quali-V
hypromellose. In addition, the company offers a proprietary product line of
capsule filling equipment, sealing machinery, check weighing equipment, and
capsule and tablet inspection equipment. It is a full-service provider striving
to be the premier global supplier of two-piece capsules and related equipment.
Qualicaps maintains a location in Whitsett, N.C.
Industry
Industry Biotechnology and Drugs
ANZSIC 2006: 184 -
Pharmaceutical and Medicinal Product Manufacturing
NACE 2002: 244 - Manufacture
of pharmaceuticals, medicinal chemicals and botanical products
NAICS 2002: 32541 -
Pharmaceutical and Medicine Manufacturing
UK SIC 2003: 244 - Manufacture
of pharmaceuticals, medicinal chemicals and botanical products
US SIC 1987: 2834 -
Pharmaceutical Preparations
Key Executives
(Emails Available)
|
Name |
Title |
|
Michael Sarno |
President & Chief Executive Officer |
|
Glen Broadstreet |
Chief Financial Officer |
|
Angie Roberson |
Manager-Marketing |
|
Dean Baunts |
Director-Information Technology &
Telecommunications |
|
Scott Graham |
Director-Purchasing |
1 - Profit & Loss Item Exchange Rate: USD 1 = USD 1
2 - Balance Sheet Item Exchange Rate: USD 1 = USD 1
Corporate Overview
Location
6505 Franz Warner Pkwy
Whitsett, NC, 27377-9215
Guilford County
United States
Tel: 336-449-7300
Fax: 336-449-3333
Toll Free Tel: 800-227-7853
Web: www.qualicaps.com
Sales USD(mil): 6.0
Assets USD(mil): NA
Employees: 175
Industry: Biotechnology
and Drugs
Incorporation Date: 1995
Company Type: Private
Subsidiary
Quoted Status: Not
Quoted
President & Chief
Executive Officer: Michael
Sarno
Contents
· Industry Codes
· Business Description
· Financial Data
· Additional Information
Industry Codes
ANZSIC 2006 Codes:
184 - Pharmaceutical and Medicinal Product Manufacturing
NACE 2002 Codes:
244 - Manufacture of pharmaceuticals, medicinal chemicals and
botanical products
NAICS 2002 Codes:
32541 - Pharmaceutical and Medicine Manufacturing
US SIC 1987:
2834 - Pharmaceutical Preparations
UK SIC 2003:
244 - Manufacture of pharmaceuticals, medicinal chemicals and
botanical products
Business
Description
Establishments
primarily engaged in the wholesale distribution of prescription drugs,
proprietary drugs, druggists' sundries, and toiletries.
More Business
Descriptions
The pharmaceutical
and dietary supplement industries throughout the world count on Qualicaps to
supply hard two-piece capsules and related manufacturing equipment. With
manufacturing sites in the United States, Europe and Japan, customers can rely
on quick service no matter where they are located. With more than 100 years in
the business, the company has a proven track record in providing the highest
quality capsules. It supplies standard capsules made from gelatin and Quali-V
hypromellose. In addition, the company offers a proprietary product line of
capsule filling equipment, sealing machinery, check weighing equipment, and
capsule and tablet inspection equipment. It is a full-service provider striving
to be the premier global supplier of two-piece capsules and related equipment.
Qualicaps maintains a location in Whitsett, N.C.
|
||||||||||||||||
|
||||||||||||||||
Credit Report as of 02/01/2011
|
Location |
|
|
6505 Franz Warner Pkwy |
|
|
|
|
|
County: |
Guilford |
|
MSA: |
Grn-Wn-Slm, NC |
|
|
|
|
Phone: |
336-449-7300 |
|
Fax: |
336-449-3333 |
|
Toll Free: |
800-227-7853 |
|
URL: |
|
|
|
|
|
ABI©: |
491752127 |
|
|
|
|
Annual Sales: |
$6,048,000 (USD) |
|
Employees: |
175 |
|
|
|
|
Facility Size(ft2): |
40,000+ |
|
|
|
|
Business Type: |
Private |
|
Location Type: |
Single Location |
|
RECOMMENDED
CREDIT LIMIT * |
|
|
$25,000 (USD) |
|
|
|
|
|
Primary Line of
Business: |
|
|
SIC: |
5122-03 - Pharmaceutical Products-Wholesale |
|
NAICS: |
424210 - Druggists' Goods Merchant Whols |
|
Secondary Lines
of Business: |
|
|
NAICS: |
325412 - Pharmaceutical Preparation Mfg |
|
SICs: |
2834-04 - Drug Millers (Mfrs) |
|
|
2899-18 - Gelatine (Mfrs) |
|
|
3999-03 - Manufacturers |
|
|
5099-05 - Importers (Whls) |
|
|
9999-66 - Federal Government Contractors |
|
|
423990 - All Other Durable Goods Merchant Whols |
|
|
339999 - All Other Misc Mfg |
|
|
325199 - All Other Basic Organic Chemical Mfg |
|
|
Table of Contents
· Profile Links
· Similar Businesses in the Area
· Closest Neighbors
External Links
· Similar Businesses in the Area *
Cardinal Health
309 S Westgate Dr Ste: G
Greensboro, NC 27407-1634
PHD
Pharmaceuticals
301 S Elm St Ste: 305
Greensboro, NC 27401-2636
Bana
Pharmaceuticals
8646 W Market St
Greensboro, NC 27409-9404
Mylan
Pharmaceuticals Inc
105 E J J Dr
Greensboro, NC 27406
Banner Pharmacaps
Inc
4100 Mendenhall Oaks Pkwy Ste: 301
High Point, NC 27265-8075
Mylan
Pharmaceuticals Inc
2898 Manufacturers Rd
Greensboro, NC 27406-4600
Pharma Care
447 S Spring St
Burlington, NC 27215-5864
Banner Pharmacaps
Inc
4125 Premier Dr
High Point, NC 27265-8144
Cardinal Health
4 Cardinal Health Ct
Greensboro, NC 27407-2647
Accredo
Therapeutics
422 Gallimore Dairy Rd
Greensboro, NC 27409-9725
* Similar Businesses are defined
as the closest businesses sharing the same six-digit primary SIC code ( 5122-03
- Pharmaceutical Products-Wholesale) regardless of size.
Closest Neighbors
Metaldyne Corp
6491 Franz Warner Pkwy
Whitsett, NC 27377-9214
Medi USA
6481 Franz Warner Pkwy
Whitsett, NC 27377-9214
Mel's Pressure
Washing Services
1307 Rock Creek Dairy Rd
Whitsett, NC 27377-9719
Engineered Controls
International Inc
1239 Rock Creek Dairy Rd
Whitsett, NC 27377-9116
Bottom of Form
|
Corporate Family |
Corporate Structure News: |
|
|
|
|
Total Corporate Family Members: 14 |
|
|
|
|
|
Company Name |
Company Type |
Location |
Country |
Industry |
Sales |
Employees |
|
|
Parent |
Osaka |
Japan |
Biotechnology and Drugs |
3,295.0 |
5,277 |
|
|
|
Acquisition of C
& O Pharmaceutical Tech (Holdings) Ltd proposed/announced.See corporate
structure news on
Shionogi & Co., Ltd. for details |
|||||||
|
Subsidiary |
Alcobendas, Madrid |
Spain |
Biotechnology and Drugs |
54.3 |
234 |
|
|
|
Subsidiary |
Whitsett, NC |
United States |
Biotechnology and Drugs |
6.0 |
175 |
|
|
|
Subsidiary |
Yamato Koriyama |
Japan |
Medical Equipment and Supplies |
|
282 |
|
|
|
Subsidiary |
Taipei |
Taiwan |
Biotechnology and Drugs |
1.0 |
170 |
|
|
|
Subsidiary |
Atlanta, GA |
United States |
Biotechnology and Drugs |
382.3 |
150 |
|
|
|
Subsidiary |
San Diego, CA |
United States |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Westlake, TX |
United States |
Biotechnology and Drugs |
14.8 |
22 |
|
|
|
Branch |
Taipei |
Taiwan |
Biotechnology and Drugs |
1.0 |
150 |
|
|
|
Subsidiary |
Osaka |
Japan |
Healthcare Facilities |
1.0 |
|
|
|
|
Subsidiary |
Koka |
Japan |
Biotechnology and Drugs |
1.0 |
|
|
|
|
Subsidiary |
Osaka |
Japan |
Biotechnology and Drugs |
1.0 |
|
|
|
Executive report
|
Executives |
|
|
|
|
|||
|
President & Chief Executive Officer |
Chief Executive Officer |
|
|||
|
Chief Financial Officer |
Finance Executive |
|
|||
|
Controller |
Controller |
|
|||
|
Manager-Human Resources |
Human Resources Executive |
|
|||
|
Vice President Sales, Marketing |
Marketing Executive |
|
|||
|
Manager-Marketing |
Marketing Executive |
|
|||
|
Marketing Associate |
Marketing Executive |
|
|||
|
Director-Information Technology & Telecommunications |
Information Executive |
|
|||
|
Technical Services Rep |
Engineering/Technical Executive |
|
|||
|
Chemist |
Research & Development Executive |
|
|||
|
Director-Purchasing |
Purchasing Executive |
|
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.45.61 |
|
UK Pound |
1 |
Rs.75.32 |
|
Euro |
1 |
Rs.65.68 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or
its officials.